Pacemaker or Defibrillator Surgery without Interruption of Anticoagulation
From: the New Englad Journal of Medicine
Many patients requiring pacemaker or implantable cardioverter–defibrillator (ICD) surgery are taking warfarin. For patients at high risk for thromboembolic events, guidelines recommend bridging therapy with heparin; however, case series suggest that it may be safe to perform surgery without interrupting warfarin treatment. There have been few results from clinical trials to support the safety and efficacy of this approach.
< Back | Printer Friendly Page